Gardasil is a vaccine, licensed for use in June 2006, by the FDA. It targets four strains of human papillomavirus (HPV) -- HPV-6, 11, 16, and 18. HPV-16 and HPV-18 account for about 70% of all ...

Vaccines that protect against the types of human papillomavirus (HPV) most commonly associated with squamous cell cervical carcinoma are nearing approval in the U.S. But how long will these ...

Recent research has shed light on the wider impact of the HPV vaccine, offering protection against various other cancers, and certain health issues January marks Cervical Cancer Awareness Month, a ...

A new study shows that one or two doses of the HPV vaccine can be as effective against severe cervical changes as three doses for girls and young women. The findings could have significant ...

she said that the vaccine is directed against the strains of the HPV. The age at which the vaccine is recommended is: the best protection between 9-14 years of age: in this age group 2 doses are ...